BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15791686)

  • 1. GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects.
    Klabunde T; Evers A
    Chembiochem; 2005 May; 6(5):876-89. PubMed ID: 15791686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug design strategies for targeting G-protein-coupled receptors.
    Klabunde T; Hessler G
    Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application.
    Kratochwil NA; Malherbe P; Lindemann L; Ebeling M; Hoener MC; Mühlemann A; Porter RH; Stahl M; Gerber PR
    J Chem Inf Model; 2005; 45(5):1324-36. PubMed ID: 16180909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
    Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
    Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
    Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
    Bodenstein J; Venter DP; Brink CB
    J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a systems biology approach of-G protein-coupled receptor signalling: challenges and expectations.
    Heitzler D; Crépieux P; Poupon A; Clément F; Fages F; Reiter E
    C R Biol; 2009 Nov; 332(11):947-57. PubMed ID: 19909918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of neurohormone GPCRs present in the fruitfly Drosophila melanogaster and the honey bee Apis mellifera.
    Hauser F; Cazzamali G; Williamson M; Blenau W; Grimmelikhuijzen CJ
    Prog Neurobiol; 2006 Sep; 80(1):1-19. PubMed ID: 17070981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide inventory of neurohormone GPCRs in the red flour beetle Tribolium castaneum.
    Hauser F; Cazzamali G; Williamson M; Park Y; Li B; Tanaka Y; Predel R; Neupert S; Schachtner J; Verleyen P; Grimmelikhuijzen CJ
    Front Neuroendocrinol; 2008 Jan; 29(1):142-65. PubMed ID: 18054377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modeling and docking evaluation of aminergic G protein-coupled receptors.
    McRobb FM; Capuano B; Crosby IT; Chalmers DK; Yuriev E
    J Chem Inf Model; 2010 Apr; 50(4):626-37. PubMed ID: 20187660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-binding modes in cationic biogenic amine receptors.
    Ishiguro M
    Chembiochem; 2004 Sep; 5(9):1210-9. PubMed ID: 15368572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting neurotrophic effects by GPCR ligands.
    Jeanneteau F; Chao MV
    Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand screening system using fusion proteins of G protein-coupled receptors with G protein alpha subunits.
    Suga H; Haga T
    Neurochem Int; 2007; 51(2-4):140-64. PubMed ID: 17659814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and exploration of target-selective chemical space representations.
    Vogt I; Bajorath J
    J Chem Inf Model; 2008 Jul; 48(7):1389-95. PubMed ID: 18558671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics-based discovery and identification of new biologically active peptides for GPCR deorphanization.
    Colette J; Avé E; Grenier-Boley B; Coquel AS; Lesellier K; Puget K
    J Pept Sci; 2007 Sep; 13(9):568-74. PubMed ID: 17694568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs.
    Hsu SH; Luo CW
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1021-9. PubMed ID: 17652154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.